Search All Patents in Cannabis: Compositions
Patent US10617722
Issued 2020-04-14
Honey-cannabinoid Therapeutic Composition
Honey-cannabinoid therapeutic compositions and methods. A therapeutic composition providing therapeutic effects to at least some patients is described including honey; at least one cannabinoid; and optionally, at least two non-cannabinoid cannabis compounds, hydrogen peroxide, at least one food-approved antioxidant, glucose oxidase, and/or catalase, and water; where the composition is homogeneous; has oxidative power low enough to keep tetrahydrocannabinol oxidation at a rate of less than 20% per month; contains hydrogen peroxide at a concentration low enough to keep tetrahydrocannabinol oxidation at a rate of less than 20% per month; contains at least one food-approved antioxidant at a concentration low enough to keep THC oxidation at a rate of less than 20% per month; contains glucose oxidase at a concentration low enough to keep tetrahydrocannabinol oxidation at a rate of less than 20% per month; and/or contains catalase at a concentration high enough to keep tetrahydrocannabinol oxidation at a rate of less than 20% per month.
Much More than Average Length Specification
View the Patent Matrix® Diagram to Explore the Claim Relationships
USPTO Full Text Publication >
- 1. A therapeutic composition providing therapeutic effects to at least some patients comprising,
(i) honey; (ii) at least one cannabinoid; and (iii) optionally, at least two non-cannabinoid cannabis compounds, hydrogen peroxide, at least one food-approved antioxidant, glucose oxidase, and/or catalase, and (iv) water at a concentration of less than 26% by weight; wherein the composition is characterized by two or more of: (a) being homogeneous; (b) having oxidative power low enough to keep tetrahydrocannabinol oxidation at a rate of less than 20% per month; (c) containing hydrogen peroxide at a concentration low enough to keep tetrahydrocannabinol oxidation at a rate of less than 20% per month; (d) containing at least one food-approved antioxidant at a concentration low enough to keep THC oxidation at a rate of less than 20% per month; (e) containing glucose oxidase at a concentration low enough to keep tetrahydrocannabinol oxidation at a rate of less than 20% per month; and/or (f) containing catalase at a concentration high enough to keep tetrahydrocannabinol oxidation at a rate of less than 20% per month.
